Skip to main content

Advertisement

SpringerLink
Log in

Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Dramatic changes have occurred in our understanding of the etiology of the growth retardation associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD) during the past 50 years. Significant interest has been focused on preventing and/or correcting the growth retardation because of the emergence of the dual therapeutic modalities of dialysis and renal transplantation to prolong the lives of infants, children, and adolescents afflicted with CKD and ESRD. These efforts have resulted in a significant improvement in the height Z-score over the past two decades of children with CKD and ESRD. This has had a salutary impact on the final adult height of such children which should hopefully lead to an enhanced quality of life in the future. This report addresses the progress that has been made in the management of growth retardation in the pediatric population with CKD and ESRD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Tönshoff B, Fine RN (2005) Growth and growth hormone treatment in children with chronic renal insufficiency. In: Nissenson AR (ed) Clinical dialysis. McGraw-Hill, New York, pp 611–651

    Google Scholar 

  2. Mahesh S, Kaskel F (2008) Growth hormone axis in chronic kidney disease. Pediatr Nephrol 23:41–48

    Article  PubMed  Google Scholar 

  3. Mak RH, Cheung WW, Roberts CT Jr (2008) The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res 18:17–25

    Article  CAS  PubMed  Google Scholar 

  4. Tönshoff B, Kiepe D, Ciarmatori S (2005) Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 20:279–289

    Article  PubMed  Google Scholar 

  5. Postel-Vinay MC, Tar A, Crosnier H, Broyer M, Rappaport R, Tönshoff B, Mehls O (1991) Plasma growth hormone-binding activity is low in uraemic children. Pediatr Nephrol 5:545–547

    Article  CAS  PubMed  Google Scholar 

  6. Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F (2005) Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatr Nephrol 20:313–318

    Article  PubMed  Google Scholar 

  7. Tönshoff B, Blum WF, Mehls O (1996) Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease. Pediatr Nephrol 10:269–274

    PubMed  Google Scholar 

  8. Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O (1991) Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 5:539–544

    Article  CAS  PubMed  Google Scholar 

  9. Bereket A, Lang CH, Blethen SL, Kaskel FJ, Steward C, Wilson TA (1997) Growth hormone treatment in growth retarded children with end stage renal failure: effect on free/dissociable IGF-1 levels. J Pediatr Endocrinol Metab 10:197–202

    CAS  PubMed  Google Scholar 

  10. Schaefer F, Veldhuis JD, Stanhope R, Jones J, Scharer K (1994) Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. Cooperative Study Group of Pubertal development in Chronic Renal Failure. J Clin Endocrinol Metab 78:1298–1306

    Article  CAS  PubMed  Google Scholar 

  11. Furth SL, Hwang W, Yang C, Neu AM, Fivosh BA, Powe NR (2002) Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 17:450–455

    Article  PubMed  Google Scholar 

  12. Rosenkranz J, Reichwald-Klugger E, Oh J, Turzer M, Mehls O, Schaefer F (2005) Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease. Pediatr Nephrol 20:1288–1294

    Article  PubMed  Google Scholar 

  13. Broyer M, Le Bihan C, Charbit M, Guest G, Tet MJ, Gagnadoux MF, Niaudet P (2004) Long-term social outcome of children after kidney transplantation. Transplantation 77:1033–1037

    Article  PubMed  Google Scholar 

  14. Betts PR, Magrath G (1974) Growth pattern and dietary intake of children with chronic renal insufficiency. Br Med J 2:189–193

    Article  CAS  PubMed  Google Scholar 

  15. Centers for Disease Control and Prevention, National Center for Health Statistics, CDC Growth Charts. Available at: http://www.cdc.gov/growthcharts/clinical_charts.htm. Accessed 8 Oct 2009

  16. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) 2008 annual report. Available at: https://web.emmes.com/study/ped/annlrept/annlrept.html. Accessed 8 Oct 2009

  17. Van Dyck M, Bilem N, Proesmans W (1999) Conservative treatment for chronic renal failure from birth: a 3-year follow-up study. Pediatr Nephrol 13:865–869

    Article  PubMed  Google Scholar 

  18. Salusky IB, Ramirez JA, Oppenheim WL, Gales B, Segre GV, Goodman WH (1994) Biochemical markers of renal osteodystrophy in pediatric patient undergoing CAPD/CCPD. Kidney Int 45:253–258

    Article  CAS  PubMed  Google Scholar 

  19. Schaefer F, Seidel C, Binding A, Gasser T, Largo RH, Prader A, Schärer K (1990) Pubertal growth in chronic renal failure. Pediatr Res 28:5–10

    Article  CAS  PubMed  Google Scholar 

  20. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) 2007 annual report. Available at: https://web.emmes.com/study/ped/annlrept/annlrept.html. Accessed 8 Oct 2009

  21. Saland JM, Guisberg HN (2007) Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 22:1095–1112

    Article  PubMed  Google Scholar 

  22. Kaufman DB (1998) Growth hormone and renal osteodystrophy: a case report. Pediatr Nephrol 12:157–159

    Article  CAS  PubMed  Google Scholar 

  23. Blethen SL, Rundle AC (1996) Slipped capital femoral epiphysis in children treated with growth hormone. A summary of the National Cooperative Growth Study Experience. Horm Res 46:113–116

    Article  CAS  PubMed  Google Scholar 

  24. Reeves GD, Doyle DA (2002) Growth hormone treatment and pseudotumor cerebri: coincidence or close relationship? J Pediatr Endocrinol Metab 15:723–730

    CAS  PubMed  Google Scholar 

  25. Radetti G, Crepaz R, Paganini C, Gentili L, Pitscheider W (1999) Medium-term cardiovascular effects of high-dose growth hormone treatment in growth hormone-deficient children. Horm Res 52:247–252

    Article  CAS  PubMed  Google Scholar 

  26. Fine RN, Kohaut EC, Brown D, Perlman AJ, the Genentech Cooperative Study Group (1994) Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 124:374–382

    Article  CAS  PubMed  Google Scholar 

  27. Vimalachandra D, Craig JC, Cowell CT, Knight JF (2001) Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. J Pediatr 139:560–567

    Article  CAS  PubMed  Google Scholar 

  28. Mencarelli F, Kiepe D, Leozappa G, Stringini G, Cappa M, Emma F (2009) Growth hormone treatment started in the first year of life with chronic renal failure. Pediatr Nephrol 24:1039–1046

    Article  PubMed  Google Scholar 

  29. Fine RN, Kohaut E, Brown D, Kuntze J, Attie KM (1996) Long term (5-year) Treatment of growth retarded children with Chronic Renal Insufficiency, (CRI), with Recombinant Human Growth Hormone (rhGH). Kidney Int 49:781–785

    Article  CAS  PubMed  Google Scholar 

  30. Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J (2000) Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 14:701–706

    Article  CAS  PubMed  Google Scholar 

  31. Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Mehls O, the German study group for growth hormone treatment in chronic renal failure (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. N Engl J Med 343:923–930

    Article  CAS  PubMed  Google Scholar 

  32. Bérard E, André JL, Guest G, Berthier F, Afanetti M, Cochat P, Broyer M, French Society for Pediatric Nephrology (2008) Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology. Pediatr Nephrol 23:2031–2038

    Article  PubMed  Google Scholar 

  33. Bérard E, Crosnier H, Six-Beneton A, Chevallier T, Cochat P, Broyer M, French Society of Pediatric Nephrology (1998) Recombinant human growth hormone treatment of children on hemodialysis. Pediatr Nephrol 12:304–310

    Article  PubMed  Google Scholar 

  34. Jabs K, Sullivan EK, Avner ED, Harmon WE (1996) Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 61:31–36

    Article  CAS  PubMed  Google Scholar 

  35. Chakrabarti P, Wong HY, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Hakala TR, Fung JJ, Simmons RL, Starzl TE, Shapiro R (2000) Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 70:760–764

    Article  CAS  PubMed  Google Scholar 

  36. Li L, Chang A, Naesens M, Kambham N, Waskerwitz J, Martin J, Wong C, Alexander S, Grimm P, Concepcion W, Salvatierra O, Sarwal MM (2009) Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patients benefits. Am J Transplant 9:1362–1372

    Article  CAS  PubMed  Google Scholar 

  37. Tejani A, Fine R, Alexander S, Harmon W, Stablein D (1993) Factors predictive of sustained growth in children after renal transplantation. J Pediatr 122:397–402

    Article  CAS  PubMed  Google Scholar 

  38. Hokken-Koelega AC, Stijnen T, de Jong RC, Donckerwolcke RA, Groothoff JW, Wolff ED, Blum WF, de Muinck Keizer-Schrama SM, Drop SL (1996) A placebo-controlled double-blind trial of growth hormone treatment in prepubertal children with renal allografts. Kidney Int Suppl 53:S128–134

    CAS  PubMed  Google Scholar 

  39. Maxwell H, Rees L (1998) Randomised controlled trial of recombinant human growth hormone in prepubertal renal transplant recipients. Arch Dis Child 79:481–487

    Article  CAS  PubMed  Google Scholar 

  40. Guest G, Bérard E, Crosnier H, Chevallier T, Rappaport R, Broyer M (1998) Effects of growth hormone in short children after renal transplantation. Pediatr Nephrol 12:437–446

    Article  CAS  PubMed  Google Scholar 

  41. Fine RN, Stablein D, Cohen A, Tejani A, Kohaut E (2002) Recombinant human growth hormone (rhGH) post-renal transplantation in children: Randomized one year controlled study of the North American pediatric renal transplant cooperative study (NAPRTCS). Kidney Int 62:688–696

    Article  CAS  PubMed  Google Scholar 

  42. Mehl O (2002) Does growth hormone treatment affect the risk of post-transplant renal cancer? Pediatr Nephrol 17:984–989

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, Stony Brook University Medical Center, Stony Brook, NY, 11794, USA

    Richard N. Fine

Authors
  1. Richard N. Fine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard N. Fine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fine, R.N. Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Pediatr Nephrol 25, 725–732 (2010). https://doi.org/10.1007/s00467-009-1409-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-009-1409-1

Keywords

Search

Navigation